Rare diseases
Investigational molecules
Locations
Back to Czechia65 clinical trials in Ceske Budejovice, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on Risankizumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease
CzechiaCzechiaStudy on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment
CzechiaStudy of ExPEC9V vaccine for preventing invasive E.
CzechiaStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection
CzechiaStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
CzechiaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
CzechiaStudy of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes
CzechiaStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Current trials focus on evaluating novel treatments for respiratory syncytial virus (RSV) and Clostridioides difficile infections. Studies are investigating the effectiveness of vaccines against meningococcal infections in infants and examining immune responses to influenza vaccines in older adults.
Particular attention is being paid to vaccine development and optimization of treatment durations.
Extensive research is underway in treating inflammatory bowel diseases, with multiple trials examining new therapies for both Crohn's Disease and Ulcerative Colitis. Studies are evaluating various biological treatments and their effectiveness in managing moderate to severe cases.
These trials aim to improve treatment outcomes and quality of life for patients with chronic gastrointestinal conditions.
Studies are investigating new approaches to prevent stroke and manage cardiovascular complications in patients with atrial fibrillation. Research includes evaluation of novel medications for acute myocardial infarction and stroke prevention strategies.
Focus is on developing rapid-response treatments and preventive therapies for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
